Stoltz Petronella, Manworren Renee C B
Division of Pediatric Critical Care, Connecticut Children's Medical Center, Hartford, CT, United States; Division of Pediatric Neurosurgery, Connecticut Children's Medical Center, Hartford, CT, United States.
Nursing Research & Professional Practice, Posey and Fred Love Chair in Nursing Research, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States; (d)Northwestern University Feinberg School of Medicine, United States.
J Pediatr Nurs. 2017 Nov-Dec;37:91-96. doi: 10.1016/j.pedn.2017.08.025. Epub 2017 Aug 18.
Needle procedures, like venipuncture and intravenous (IV) catheter insertion, are recognized as a common cause of pain and fear for children in hospitals and emergency departments. The purpose of this study was to compare children's self-reported pain and fear related to IV insertion with administration of either the topical local anesthetic EMLA® or 1% buffered lidocaine delivered with the J-Tip Needleless Injection System® (J-Tip®).
In this prospective, randomized trial, 150 consecutive pediatric patients 8 to 18years of age undergoing IV insertion were randomly assigned 1:1 to treatment group. Participants self-reported procedural pain using a Visual Analog Scale, and procedural fear using the Children's Fear Scale.
Procedural pain scores were significantly lower in the EMLA® group (mean score 1.63+1.659) vs. the J-Tip® group (2.99±2.586; p<0.001). Post-procedure fear scores were significantly lower than pre-procedure fear scores in both treatment groups (p<0.002), but there was no difference in fear scores between the two treatment groups (p=0.314).
EMLA® provided superior pain relief for IV insertion compared to J-Tip®.
Although EMLA® use resulted in lower self-reported pain scores compared to J-Tip®, pain scores for both treatments were low and fear scores did not differ. When IV insertion can be delayed for 60-90min, EMLA® should be used. When a delay is contraindicated, J-Tip® may be a reasonable alternative to minimize procedural pain of IV insertion.
诸如静脉穿刺和静脉内(IV)导管插入等针刺操作,被认为是医院和急诊科儿童疼痛和恐惧的常见原因。本研究的目的是比较儿童在接受IV导管插入时,使用局部麻醉剂复方利多卡因乳膏(EMLA®)或通过无针注射系统J-Tip®(J-Tip®)输送的1%缓冲利多卡因时自我报告的疼痛和恐惧情况。
在这项前瞻性随机试验中,150名连续接受IV导管插入的8至18岁儿科患者被1:1随机分配到治疗组。参与者使用视觉模拟量表自我报告操作过程中的疼痛,并使用儿童恐惧量表报告操作过程中的恐惧。
与J-Tip®组(2.99±2.586)相比,EMLA®组的操作疼痛评分显著更低(平均评分1.63+1.659;p<0.001)。两个治疗组术后恐惧评分均显著低于术前恐惧评分(p<0.002),但两个治疗组之间的恐惧评分没有差异(p=0.314)。
与J-Tip®相比,EMLA®在IV导管插入时提供了更好的疼痛缓解效果。
尽管与J-Tip®相比,使用EMLA®导致自我报告的疼痛评分更低,但两种治疗的疼痛评分都很低,恐惧评分没有差异。当IV导管插入可以延迟60 - 90分钟时,应使用EMLA®。当延迟插入存在禁忌时,J-Tip®可能是一种合理的选择,以尽量减少IV导管插入的操作疼痛。